SpainOn September 7, 2026, Seville-based biotech startup Vaxdyn SL secured an investment of 11 million euros, becoming one of the companies receiving funding from the Andalusian Regional Government's risk capital fund. The company, founded by Juanjo Infante, specializes in developing preventive vaccines against antibiotic-resistant bacteria. It has its own platform designed to create vaccines targeting some of the most priority pathogens for global health.
Bias read (Center): The article presents factual information about a private company securing public funding without overtly criticizing or praising the government's decision. While the mention of the Andalusian Regional Government's involvement introduces a political element, the framing remains neutral, focusing on V
Why factuality: no official source document/info detected
Why objectivity (78): The article presents the information in a neutral tone, focusing on the facts of the investment round and the company's mission. However, it includes some promotional language such as 'una de las firmas que consigue financiación' which subtly highlights the achievement, potentially introducing a sli
